MENU
Research + Education
The University of Michigan Rogel Cancer Center has a distinguished history of scientific excellence, collaboration and impact in basic science, clinical research and cancer control research.
News
-
Donor pancreas tissue helps define ‘new normal’ in pancreatic cancer research
A research partnership between Michigan Medicine and Gift of Life Michigan has revealed a new pathway to understanding the progression of pancreatic cancer.Read More > -
Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer
Novel finding suggests a possible target for improving response to immune-based cancer treatmentsRead More > -
Rogel names 2 new clinical research leaders
The University of Michigan Rogel Cancer Center has named Kyle Cuneo, M.D., its new associate director for clinical research. In addition, a new position of assistant director for clinical research will be filled by John Magenau, M.D. Cuneo and Magenau will collaborate with leaders across Michigan Medicine and the University of Michigan to establish processes and infrastructure in support of cancer-focused clinical research.Read More > -
Members of the Rogel Cancer Center present at ASH 2024
The 66th American Society of Hematology 2024 annual meeting, will be Dec. 7-10 at the San Diego Convention Center in San Diego, California, and online. University of Michigan faculty and trainees will present or moderate more than two dozen sessions and posters.Read More >
Multimedia + Social Media
